Insider Transactions in Q1 2021 at Boston Scientific Corp (BSX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 21
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Payment of exercise price or tax liability
|
Direct |
1,106
-9.1%
|
$42,028
$38.03 P/Share
|
|
Feb 21
2021
|
David A Pierce EVP Pres MedSurg |
BUY
Exercise of conversion of derivative security
|
Direct |
2,492
+17.02%
|
-
|
|
Feb 19
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
1,484
-13.32%
|
$56,392
$38.0 P/Share
|
|
Feb 18
2021
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,644
-0.59%
|
$60,828
$37.52 P/Share
|
|
Feb 18
2021
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,706
+1.31%
|
-
|
|
Feb 18
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,006
-2.8%
|
$37,222
$37.52 P/Share
|
|
Feb 18
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,371
+6.19%
|
-
|
|
Feb 18
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
544
-0.29%
|
$20,128
$37.52 P/Share
|
|
Feb 18
2021
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,853
+0.96%
|
-
|
|
Feb 18
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
327
-1.79%
|
$12,099
$37.52 P/Share
|
|
Feb 18
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,111
+5.74%
|
-
|
|
Feb 18
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,829
-0.74%
|
$67,673
$37.52 P/Share
|
|
Feb 18
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
3,706
+1.48%
|
-
|
|
Feb 18
2021
|
Edward F Mackey EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
986
-1.12%
|
$36,482
$37.52 P/Share
|
|
Feb 18
2021
|
Edward F Mackey EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,223
+2.45%
|
-
|
|
Feb 18
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,232
-0.35%
|
$267,584
$37.52 P/Share
|
|
Feb 18
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,306
+0.77%
|
-
|
|
Feb 18
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
862
-0.63%
|
$31,894
$37.52 P/Share
|
|
Feb 18
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,816
+2.03%
|
-
|
|
Feb 18
2021
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
224
-0.63%
|
$8,288
$37.52 P/Share
|
|
Feb 18
2021
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
637
+1.76%
|
-
|
|
Feb 18
2021
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
305
-0.97%
|
$11,285
$37.52 P/Share
|
|
Feb 18
2021
|
Ian T Meredith EVP Global Chief Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,037
+3.19%
|
-
|
|
Feb 18
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
SELL
Payment of exercise price or tax liability
|
Direct |
615
-0.25%
|
$22,755
$37.52 P/Share
|
|
Feb 18
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
BUY
Exercise of conversion of derivative security
|
Direct |
1,778
+0.73%
|
-
|
|
Feb 18
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
542
-4.23%
|
$20,054
$37.52 P/Share
|
|
Feb 18
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
BUY
Exercise of conversion of derivative security
|
Direct |
1,037
+7.49%
|
-
|
|
Feb 18
2021
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
363
-0.75%
|
$13,431
$37.52 P/Share
|
|
Feb 18
2021
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,185
+2.4%
|
-
|
|
Feb 18
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Payment of exercise price or tax liability
|
Direct |
1,184
-9.6%
|
$43,808
$37.52 P/Share
|
|
Feb 18
2021
|
David A Pierce EVP Pres MedSurg |
BUY
Exercise of conversion of derivative security
|
Direct |
2,668
+17.79%
|
-
|
|
Feb 18
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,084
-1.02%
|
$40,108
$37.52 P/Share
|
|
Feb 18
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,001
+1.85%
|
-
|
|
Feb 18
2021
|
Desiree Ralls Morrison SVP, GC and Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
501
-1.7%
|
$18,537
$37.52 P/Share
|
|
Feb 18
2021
|
Desiree Ralls Morrison SVP, GC and Corp Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,704
+5.47%
|
-
|
|
Feb 18
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Payment of exercise price or tax liability
|
Direct |
372
-2.54%
|
$13,764
$37.52 P/Share
|
|
Feb 18
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
1,111
+7.05%
|
-
|
|
Feb 17
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
32,353
+23.66%
|
$226,471
$7.47 P/Share
|
|
Feb 16
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
1,540
-13.75%
|
$58,520
$38.28 P/Share
|
|
Feb 15
2021
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,842
-0.67%
|
$69,996
$38.39 P/Share
|
|
Feb 15
2021
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,153
+1.48%
|
-
|
|
Feb 15
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
803
-2.34%
|
$30,514
$38.39 P/Share
|
|
Feb 15
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,846
+5.1%
|
-
|
|
Feb 15
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
488
-0.26%
|
$18,544
$38.39 P/Share
|
|
Feb 15
2021
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,661
+0.87%
|
-
|
|
Feb 15
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
2,278
-0.93%
|
$86,564
$38.39 P/Share
|
|
Feb 15
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
4,614
+1.85%
|
-
|
|
Feb 15
2021
|
Edward F Mackey EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,228
-1.41%
|
$46,664
$38.39 P/Share
|
|
Feb 15
2021
|
Edward F Mackey EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,768
+3.07%
|
-
|
|
Feb 15
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
271
-1.56%
|
$10,298
$38.39 P/Share
|